BIO-TECHNE Corp
TECH· Nasdaq
Filed Sep 7, 2017 · 10-K · 69 days after period end · 0001437749-17-015711
| Metric | Q4 2017 | Q4 2016 | Q4 2015dderived from reported figures | Q4 2014dderived from reported figures |
|---|---|---|---|---|
| Revenue | $156.58M | $134.76M | $117.66M | $92.52M |
| Net Income | $27.61M | $25.63M | $26.33M | $26.82M |
| EPS Diluted | $0.74 | $0.69 | — | — |
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Jun 30, 2017 · filed Sep 7, 2017 · 69 d after period end